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RNA polymerase III (Pol III) is tightly controlled in response to environmental cues, yet a genomic-scale picture of Pol III
regulation and the role played by its repressor MAF1 is lacking. Here, we describe genome-wide studies in human fibroblasts
that reveal a dynamic and gene-specific adaptation of Pol III recruitment to extracellular signals in an mTORC1-dependent
manner. Repression of Pol III recruitment and transcription are tightly linked to MAF1, which selectively localizes at Pol III
loci, even under serum-replete conditions, and increasingly targets transcribing Pol III in response to serum starvation.
Combining Pol III binding profiles with EU-labeling and high-throughput sequencing of newly synthesized small RNAs,
we show that Pol III occupancy closely reflects ongoing transcription. Our results exclude the long-term, unproductive ar-
rest of Pol III on the DNA as a major regulatory mechanism and identify previously uncharacterized, differential coordina-
tion in Pol III binding and transcription under different growth conditions.
[Supplemental material is available for this article.]
Cell survival and proliferation are largely controlled by the RAS/
MAPK and PI3K/mTORC1 pathways, which couple resource-de-
manding processes such as de novo synthesis of proteins, lipids,
and nucleotides to nutrient availability. Regulation of these signal-
ing pathways ensures cell growth in response to amino acid levels,
growth factors, and energy status, as well as cell survival during
periods of starvation (Mendoza et al. 2011). So far, many studies
investigating the control of protein synthesis through the PI3K/
mTORC1 pathway have focused on the ability of mTORC1
to coordinate translation initiation through S6K and 4E-BP
(Shimobayashi and Hall 2014). However, mTORC1 regulation of
RNA polymerase II (Pol II) and III (Pol III) transcription has recent-
ly emerged as a newmechanism to adapt cellular responsiveness to
extra- and intracellular cues (Laplante and Sabatini 2013; Grewal
2015).
Reflecting the highly diversified gene-expression programs
needed to effect development and cellular adaptation to external
conditions, Pol II transcription is regulated in large part on a
gene per gene basis, with each gene harboring a promoter structure
specifying Pol II recruitment under certain conditions. In addition,
Pol II is regulated at the level of transcription elongation; it is
found in a “poised” or “paused” state at the transcription start sites
(TSSs) of a large number of genes, fromwhich it can rapidly escape
into productive elongation, affording the cell with a mechanism
for a very rapid and synchronous response to changing conditions
(Adelman and Lis 2012). Compared with Pol II, RNA Pol III recog-
nizes a limited number of promoter structures, which can be
roughly classified as type I, present in the 5S rRNA genes
(RNA5S); type II, present in tRNA genes and SINEs; and type III,
present in a small collection of genes with different functions, in-
cluding the U6 snRNA (RNU6) and 7SK RNA (RN7SK) genes (Orioli
et al. 2012). This limited number of promoter structures is thought
to reflect a much simpler regulation, with the enzyme responding
mostly uniformly to growth, proliferation, or stress cues
(Harismendy et al. 2003). Indeed, elevated tRNA levels are a hall-
mark of many tumors (White et al. 1989; Pavon-Eternod et al.
2009; Zhou et al. 2009) and, in Drosophila, drive larval develop-
ment and increase in body size (Marshall et al. 2012; Rideout
et al. 2012). However, there is increasing evidence that the devel-
opmental and proliferative states of a cell are affected not only
by global tRNA levels but also by the balance between the supply
of different tRNA isoacceptors and the decoding requirements of
the mRNAs expressed in a certain tissue or developmental state
(Gingold et al. 2014; Schmitt et al. 2014). These studies point to
a more subtle regulation of Pol III transcription and, in particular,
tRNA synthesis, than suggested by the relatively uniform structure
of Pol III promoters.
While several factors contribute to the regulation of Pol III
transcription, transition fromapermissive to a restrictive transcrip-
tional state and vice versa is largely controlled by a highly con-
served Pol III repressor called Maf1 (Pluta et al. 2001). In
Saccharomyces cerevisiae, Maf1 can be inactivated by the TORC1-
controlled kinase Sch9 (Boguta andGraczyk 2011) andother kinas-
es (Moir et al. 2006) in response to nutrient availability and energy
status.UponTORC1 inhibitionbynutrient deprivationor rapamy-
cin treatment, Pol III transcription is repressed in a Maf1-depen-
dent manner, and this parallels with Maf1 dephosphorylation
and association with Pol III genes (Oficjalska-Pham et al. 2006;
Roberts et al. 2006). In mammalian cells, MAF1 is directly
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phosphorylated bymTORC1 (Michels et al. 2010; Shor et al. 2010)
and becomeshypophosphorylated in response to stress or nutrient
withdrawal, which correlates with transcriptional repression of
RNU6, RNA5S, and some tRNA genes (Reina et al. 2006; Rollins
et al. 2007; Goodfellow et al. 2008; Rohira et al. 2013). Since hypo-
phosphorylated MAF1 binds to Pol III (Reina et al. 2006), and the
physical interaction of MAF1 with recombinant Pol III prevents
closed complex formation and initiation from target gene promot-
ers in vitro (Vannini et al. 2010),MAF1 is considered as a general re-
pressor of Pol III transcription. Nevertheless, the full extent of
transcriptional repression at different subsets of genes, including
the metazoan-specific type III promoter genes, remains elusive.
Mammalian MAF1 has also been reported to repress Pol II
transcription by specifically associating with the promoter of cer-
tain mRNA genes, including TBP, FASN, and EGR1 (Johnson
et al. 2007; Palian et al. 2014). Targeting of these genes impacts dif-
ferent signaling pathways but can also affect the transcriptional
readout of other polymerases; indeed, down-regulation of TBP,
an essential component of the Pol I promoter selectivity factor
(SL1) and the Pol III–recruiting factor TFIIIB, has been proposed
to indirectly affect transcription of both Pol I and Pol III genes.
However, since genome-wide binding profiles for mammalian
MAF1 have not been reported, the full extent of MAF1-dependent
regulation of protein-coding genes remains to be addressed.
Here, we have developed and applied high-throughput strat-
egies to understand the mechanisms responsible for the adapta-
tion of Pol III transcription to prosurvival and stress cues, as well
as the role played by MAF1 in such modulation.
Results
Pol III recruitment adapts heterogeneously to environmental cues
To understand the dynamics of Pol III regulation by metabolic
pathways, we analyzed IMR90hTert cells grown in the presence
(FBS) or absence (SS) of serum, as well as serum-starved cells restim-
ulated with insulin alone (SS + I), or following addition of rapamy-
cin (SS + R + I), a highly specific inhibitor of mTORC1 (Fig. 1A; Yip
et al. 2010).Whereas serum starvation led to dephosphorylation of
RPS6S235/236, AKTS473, and MAPK3/MAPK1(ERK1/ERK2)T202/Y204,
treatment with insulin resulted in robust rephosphorylation of
these three proteins (Fig. 1B, lanes 1–3), suggesting reactivation
of both the RAS/MAPK and PI3K/mTORC1 pathways. However,
in the presence of rapamycin, insulin specifically failed to trigger
phosphorylation of RPS6S235/236, indicating suppression of down-
stream mTORC1 activity, but not RAS/MAPK signaling, under
these conditions (Fig. 1B, lane 4). Consistent with previous studies
identifying MAF1 as a substrate of mTORC1 (Michels et al. 2010;
Shor et al. 2010), MAF1 was dephosphorylated as a result of serum
deprivation and rapidly rephosphorylated after insulin stimula-
tion unless the kinase activity of mTOR was inhibited by rapamy-
cin (Fig. 1B).
To assess adaptation of Pol III recruitment to prosurvival and
stress stimuli, we determined genome-wide Pol III occupancy un-
der the different growth conditions described in Figure 1A using
an antibody against the Pol III subunit POLR3D (RPC4) (Canella
et al. 2010). After validation of Pol III binding at both type II
(TRI-TAT2-1) and type III (RNU6-1) promoter genes by locus-spe-
cific ChIP-qPCR (Supplemental Fig. S1A), we performed Pol III
ChIP-seq in IMR90hTert cells. From a set of 110–170 million
aligned reads per condition (Supplemental Table S1, column I),
we generated Pol III enrichment profiles at a compilation of 622
tRNA genes (Chan and Lowe 2009), as well as other previously
identified (Renaud et al. 2014) loci. ChIP-seq scores for Pol III en-
richment over a window extending 150 bp upstream of and down-
stream from the gene body were calculated as the mean log2 (IP/
input) of two experiments per condition. The analysis identified
489 Pol III–bound loci in actively dividing cells (FDR 0.1%; see
Methods), including tRNA genes, 5S rRNA (RNA5S) genes, and
type III promoter genes such as RNU6, RN7SK, RPPH1, and others
(Supplemental Table S2). Consistent with previous reports
(Canella et al. 2010; Moqtaderi et al. 2010; Oler et al. 2010), Pol
III was found only at 68% of annotated Pol III genes (Fig. 1C); an
80-kb region on Chromosome 6 is shown in Figure 1D as an exam-
ple, where three tRNA genes with no significant binding (gray
shading) are interspersed with Pol III–occupied loci.
Comparing Pol III occupancy scores with a DNase I hypersen-
sitive site (DHS) (Thurman et al. 2012) and histone modification
(Hawkins et al. 2010) data sets generated in the same cell type re-
vealed that unoccupied genes display lower chromatin accessibili-
ty and are generally devoid of open chromatin marks (H3K4me3,
H3K9ac, H3K27ac, H4K20me1) compared with their highly occu-
pied counterpart (Supplemental Fig. S1B,C), whereas no striking
difference was observed for repressive marks (H3K27me3,
H3K9me3). Similarly to previous results in mouse liver cells
(Canella et al. 2012), highly occupied and unoccupied genes dis-
played distinct promoter sequences (Supplemental Fig. S1D).
While we cannot establish a cause and effect relationship, these
analyses and the observation that Pol III is absent from 32% of
Pol III genes in all tested conditions (Fig. 1C) suggest that inactive
genes are in a lasting repressed state as a result of genetic and epi-
genetic features.
The mTORC1 target MAF1 controls Pol III recruitment
genome-wide
Unlike unoccupied genes, the large majority of Pol III–bound
genes displayed metabolic adaptation of Pol III recruitment, as il-
lustrated by MA-plots comparing ChIP-seq score distribution
among different growth conditions. Serum withdrawal resulted
in decreased (P < 0.005) occupancy at ∼90% of the 489 genes iden-
tified above as Pol III bound, which was rapidly rescued, though
not to the starting level, 90 min after insulin stimulation (Fig.
1E). Importantly, this recoverywas not observed in cells previously
treated with rapamycin (Fig. 1F), suggesting that, in IMR90hTert
cells, insulin control of Pol III recruitment requires mTORC1.
To determine the role of humanMAF1 in the regulation of Pol
III recruitment, we performed Pol III ChIP-seq assays in serum-
starved IMR90hTert cells transfected with a nontarget siRNA or
two different MAF1-specific siRNAs (#1 and #2). Efficient knock-
down of MAF1 by either siRNA (Fig. 2A) resulted in significantly
higher enrichment of Pol III at occupied loci versus the control
(Fig. 2B). Nonoccupied loci (Fig. 2B, gray) were mostly unaffected
byMAF1 depletion, further emphasizing that these loci are lasting-
ly repressed in this cell type. Taken together, these data show that
MAF1 reduces genome-wide Pol III occupancy under serum-
starved conditions and that this decrease correlates with the
MAF1 phosphorylation state (see Fig. 1B).
Although Pol III recruitment showedmetabolic adaptation at
themajority of sites, it did not significantly change at 49 active loci
(see Pol III gene stability sheet in Supplemental Table S2), which
we therefore refer to as “stable” in terms of Pol III occupancy after
serum starvation (Fig. 1E,F, small blue dots). These genes included
representatives of most tRNA isotypes and type III promoter genes
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and showed only moderate sensitivity to MAF1 knockdown (Fig.
2C, red dots), indicating that both environmental cues and
MAF1 have little effect on their levels of resident Pol III. While
this observationmight reflect productive transcription from a sub-
set of genes to sustain basal cellular activities during periods of star-
vation, it also raised the possibility that Pol III could occupy a gene
in an unproductive state.
Long-term, unproductive arrest of Pol III on the DNA
can be generally excluded in human fibroblasts
To address the activity of DNA-bound Pol III in serum-starved cells,
we optimized 5-ethynyl uridine (EU) metabolic labeling for selec-
tive high-throughput quantification of newly synthesized EU-la-
beled small RNAs (Fig. 3A, neusRNA-seq). Cells grown under
Figure 1. Genome-wide analysis of Pol III recruitment reveals differential occupancyprofiles under prosurvival and stress conditions. (A,B) IMR90hTert cells
weregrownin thepresence (FBS)orabsence (serum-starved, SS) of fetal bovine serumfor8h.Wethenadded1µMinsulin to starvedcells alone (SS + I) orafter
treatment with 2 nM rapamycin (SS + R + I), for the indicated times. Whole-cell extracts were subsequently analyzed by immunoblotting for total levels and
phosphorylation status of the indicated proteins. The MAF1 hyperphosphorylated forms are indicated by arrows. (C) Pie chart representation of 715 Pol III
genes either unbound (226)orbound (489) topolymerase in at leastoneof the four conditions (FBS, SS, SS + I, or SS + R + I). (D) Pol III occupancyasmeasured
by ChIP-seq, shown for a cluster of tRNA genes on Chromosome 6. Chromatin was prepared from IMR90hTert cells grown as described in A and immuno-
precipitatedwithanantibodyagainst thePOLR3D(RPC4) subunit ofPol III. InputDNAsignal is shown.Grayshadings indicatenonoccupiedgenes. tRNAgene
namesareaccording toHGNC-approvedgenenomenclature (“TR” in frontofnames is omitted for spaceconstraints). (E,F )MA-plots showingdistributionsof
Pol III occupancy scores [log2 (IP/input)] for 715 loci. In eachpanel, twocomparisons are superimposed: SSversusFBS (blue) andSS + I versus FBS (yellow) in E;
SS versus FBS (blue) and SS + R + I versus FBS (pink) in F. Gray dots leftof the dotted lines (indicating the cutoff threshold score) represent nonoccupiedgenes.
Small dots are genes that do not change significantly (P > 0.005) in each pairwise comparison. The horizontal line indicates the zero-fold change.
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normal or stress conditions were provided for 1–8 h with EU,
whichwas incorporated into nascent Pol III RNAs in a time-depen-
dent manner, as shown by Northern blotting (Fig. 3B). EU-labeled
RNAs arising from type II (tRNAs) and type III (RNY3) promoter
genes were clearly detected after 4 h in normally growing cells
(Fig. 3C, lanes 1–4), and consistent with repression of Pol III re-
cruitment upon serum starvation, expression of EU-labeled RNAs
was diminished in the absence of serum (Fig. 3C, cf. lanes 4 and
8). Importantly, treatment with actinomycin D, an inhibitor of
transcription, abolished EU labeling (Fig. 3C, lanes 9–12), confirm-
ing that the nucleotide analog was incorporated transcriptionally.
Given these results, we prepared neusRNA-seq libraries from three
biological replicates of serum-fed and serum-starved IMR90hTert
cells, either metabolically labeled with EU or mock-labeled with
DMSO for 5 h. After size selection of <400-nt RNAs, EU was biotin-
ylated with click chemistry for selective enrichment of pulse-la-
beled RNAs on streptavidin beads. A dsDNA library was then
generated from the RNA on beads and analyzed by single-end se-
quencing on a HiSeq Illumina platform. Spearman correlation of
independent replicates revealed high reproducibility of the data
(r≥ 0.98) (Supplemental Fig. S2A), and expression levels were cal-
culated as the mean score of three EU-labeled samples normalized
to the DMSO controls (neusRNA-seq scores) (Supplemental Table
S2). Consistent with transcriptional repression under stress condi-
tions, we observed a significant decrease (Student’s t-test, P < 2 ×
10−16) in neusRNA-seq scores after serum starvation (Fig. 3D)
and a correlation with ChIP-seq scores in both conditions
(r = 0.52) (Fig. 3E). Strikingly, Pol III genes were particularly deplet-
ed in the high ChIP-seq and low neusRNA-seq scores region (bot-
tom right corner of the graphs in Fig. 3E), indicating that the
presence of unproductive, arrested Pol III can be excluded at the
large majority of loci, including those with stable (Fig. 3E, red
dots) Pol III occupancy in starved cells.
Pol III occupancy correlates with unprocessed RNA levels
Alignment of tags relative to the annotated 5′-ends of Pol III genes
further confirmed a general overlap between ChIP-seq and RNA-
seq signals (Fig. 3F) and also revealed density of reads in the regions
upstream of and downstream from gene bodies. This reflects map-
ability of both mature and unprocessed neusRNAs still containing
precursor sequences extending past the annotated mature ends
(Phizicky and Hopper 2010). To distinguish between unprocessed
and processed tRNAs, we separated neusRNA-seq reads uniquely
assigned to pre-tRNAs (i.e., containing intron, 5′-leader, or 3′-trail-
er sequences) from reads corresponding tomature tRNAs (i.e., end-
ing exactly at annotated 5′- or 3′-ends or spanning exon–exon
junctions). The most significant correlation with ChIP-seq scores
was found for unprocessed tRNA reads, consistent with the idea
that quantification of pre-tRNAs closely reflects ongoing transcrip-
tion (Supplemental Fig. S2B). This was confirmed by Northern
analysis of unlabeled tRNAs in serum-fed and serum-starved
cells; while mature tRNAs levels showed little to no change after
8 h of starvation, most pre-tRNAs levels were reduced
(Supplemental Fig. S2C, middle and lower panels), in line with
the ChIP-seq and neusRNA-seq signals under the same conditions
(Supplemental Fig. S2C, upper panels). Strikingly, one of the genes
showing stable Pol III occupancy in the ChIP-seq experiments
(TRY-GTA2-1) also displayed stable expression of the correspond-
ing pre-tRNA. Taken together, these results show that Pol III en-
richment is a very good proxy of ongoing Pol III transcription,
and generally exclude the presence of DNA-bound but arrested,
unproductive Pol III in IMR90hTert cells.
MAF1 preferentially localizes at Pol III–enriched loci across
the genome
Our results show that reduced Pol III occupancy in serum-starved
IMR90hTert cells is dependent on MAF1. Previous work in yeast
has indicated that Maf1 specifically associates genome-wide with
Pol III genes under repressive conditions (Roberts et al. 2006),
but no such studies have been performed in mammalian cells.
Indeed, our own attempts at defining MAF1 binding sites across
the genome by ChIP-seq were unsuccessful (data not shown).
Figure 2. Pol III recruitment is controlled genome-wide by MAF1 in an
mTORC1-dependent manner. (A) Depletion of MAF1 by RNAi.
Immunoblots of IMR90hTert cells that were not transfected (NT) or were
transfected with a control (nontarget) siRNA or with two MAF1-specific
siRNAs (#1 and #2), and serum-starved for 8 h. (B) Violin plots showing dis-
tributions of Pol III ChIP-seq scores from IMR90hTert cells transfected as
described in A. Nonoccupied genes are in gray. The median is in each
case represented by a white asterisk. Data were analyzed with Wilcoxon
pairs tests. (∗∗∗) P < 0.001. (C) MA-plot comparing Pol III occupancy scores
in MAF1 knockdown cells (mean of #1 and #2 MAF1 siRNAs) versus the
control (#NEG siRNA). Gray dots left of the dotted lines (indicating the cut-
off threshold score) represent nonoccupied genes. The horizontal line in-
dicates the zero-fold change. Red dots indicate stable genes as defined
in Pol III ChIP-seq experiments.
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We reasoned that since MAF1 alone cannot bind nucleic acids
(Desai et al. 2005) and since binding of MAF1 to Pol III prevents
its recruitment to the preinitiation complex in vitro (Vannini
et al. 2010), any interaction betweenMAF1 and Pol III–transcribed
genesmight be highly transient in nature.We therefore decided to
use DamIP-seq (Xiao et al. 2012), a technique that, similarly to
Figure 3. neusRNA-seq reveals correlation between Pol III enrichment and expression during stress conditions. (A) Outline of the neusRNA-seq protocol.
(B,C) Northern blot analysis showing time-dependent, cotranscriptional incorporation of 5-ethynyl uridine (EU) into Pol III–transcribed RNAs. Probes iden-
tify EU-labeled RNAs from the RN7SL1 and RNY3 genes or multiple tRNAs from a collection of proline (tRNA-Pro), aspartate (tRNA-Asp), and valine (tRNA-
Val) isoacceptor tRNA genes. In B, DMSO (8 h) or 0.25 mM EU was added to cell media for the indicated times. In C, RNA from IMR90hTert cells grown in
the presence or absence of serum (5 h) was pulse labeled with 0.25 mM EU for 5 h. 5 μg/mL actinomycin D (actD) was added where noted. (I) Twenty
percent input RNA; (AP) streptavidin bead affinity purified EU-labeled RNAs. (D) Scatterplot comparing levels of EU-labeled Pol III–transcribed RNAs in dif-
ferent growth conditions (+ serum vs. −serum). (E) Scatterplots showing correlation of ChIP-seq and neusRNA-seq scores at Pol III–enriched loci for both
serum-grown (upper panel) and serum-starved (lower panel) IMR90hTert cells. Red dots indicate genes defined as “stable” in Pol III ChIP-seq experiments.
The Pearson correlation coefficient (r) is given. (F) Heatmaps showing correlation of Pol III binding (left) with gene transcription levels measured by
neusRNA-seq (right). Pol III genes are split by promoter type and ranked by Pol III occupancy scores in the FBS sample. The heatmaps show sequencing
read intensity centered on the annotated 5′ of genes (which for tRNA genes correspond to the 5′-end of the mature tRNA) and extending ±1.5 kb for
ChIP-seq or −0.2/+0.5 kb for neusRNA-seq. Negative scores are set to zero.
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DamID-seq (Luo et al. 2011), relies on the fusion of a potential
chromatin binding protein to the Eserichia coliDNAadeninemeth-
yltransferase (Dam). When expressed in vivo, the Dam moiety is
tethered to its partner’s DNA binding site, where it methylates
N6-adenosine within the “GATC” recognition motif, leaving a co-
valent and uniquemark that is normally absent in eukaryotic DNA
(van Steensel et al. 2001; Greil et al. 2006). Instead of using wild-
type Dam, we fused our proteins of interest to DamK9A, a mutant
with reduced enzymatic activity and looser recognition require-
ments (Horton et al. 2006). DamK9A canmethylate the first nucle-
otide of the more frequent “ATC” target site, which is present
within 150 bp of 98% of Pol III genes.
We generated IMR90hTert stable cell lines expressing HA-
tagged MAF1-DamK9A and EGFP-DamK9A under the control of
the weak MoMuLV promoter and validated the expression of
full-length chimeric proteins by RT-PCR and immunoblotting of
both whole-cell extracts and α-HA immunoprecipitates (Fig. 4A,
B). The EGFP-DamK9A control, for which nuclear enrichment
was confirmed by fluorescence microscopy (Supplemental Fig.
S3A), is essential to normalize for local chromatin accessibility
and stochastic DNA methylation. We first assessed methylation
enrichment over the control by measuring differential sensitivity
to DpnII or Sau3AI digestion at several Pol III loci. Genomic
DNA (gDNA) from serum-starved MAF1-DamK9A and EGFP-
DamK9A–expressing cell lines was digested with either enzyme
and analyzed by qPCR with tDNA-specific primers bracketing a
DpnII/Sau3AI site. Since adenomethylated GATC is protected
from digestion by DpnII but not by Sau3AI, which cleaves its
GATC target regardless of methylation, an amplification product
is expected only at methylated loci after DpnII digestion (Fig.
4C, upper panel). The assay revealed significantly higher methyl-
ation at Pol III–bound loci (TRL-TAA1-1, TRR-TCG5-1, and TRF-
GAA1-6) for both MAF1-DamK9A clones over the EGFP-DamK9A
controls; notably, a higher signal in the clone (MAF1-A) expressing
higher levels of MAF1-DamK9A was detected, as expected for
MAF1-driven tethering of DamK9A at these genes (Fig. 4C, lower
panel, cf.MAF1-A andMAF1-B clones). Interestingly, no difference
between the controls andMAF1-DamK9A–expressing cells was ob-
served at a Pol III–unbound locus (TRN-GTT20-1), suggesting that
Pol III is required to recruit MAF1 at tRNA genes.
To extend the analysis of MAF1 target sites to the genomic
scale, we performed DamIP-seq with MAF1-DamK9A and
EGFP-DamK9A clones. gDNA from cells grown in complete or se-
rum-deprivedmediumwas sonicated, denatured, and immunopre-
cipitated with an α-N6-methyladenosine antibody. Following
second-strand synthesis, enrichedmethylatedDNAwas used for li-
brary preparation and single-end sequencing with the HiSeq
Illumina platform. To reduce the effects of clone-to-clone variabil-
ity and to increase signal, a single meta-sample was generated by
pooling together four data sets per condition (biological replicates
ofMAF1-A +MAF1-B andof EGFP-A + EGFP-B). The analysis identi-
fied about 1500 (in serum-starved cells) and 8000 (in serum-grown
cells) 400-bp bins across the genome having a positive score and a
FDR < 0.005 (see Methods; Supplemental Table S3). However, the
large majority of bins had low scores and were positioned within,
or in proximity of, repeat elements. We also observed low levels
of MAF1-DamK9A methylation at 264 Pol II genes (Supplemental
Table S3), but we did not identify enrichment at specific features
such as TSSs or promoters (Supplemental Fig. S3B). Much higher
scores were observed for bins overlapping with Pol III genes (Fig.
4D, triangles), indicating preferential binding of MAF1 to these
loci. Tag profiling around the TSS of “isolated” tRNA genes, i.e.,
tDNAs separated from one another by at least 2 kb, and of type III
promoter genes further revealed the accumulationof reads in prox-
imity of the gene body compared with the genomic surroundings
or with random intergenic regions (Fig. 4E). MAF1 interaction
was mainly observed at Pol III–bound tRNA genes, whereas only a
weak associationwas seen at Pol III–unbound tRNAgenes. This dis-
tribution appeared not to be biased by the relative ATC content, as
many Pol III genes displayed low scores but high ATC frequencies
(Supplemental Fig. S3C). Overall, higher MAF1 scores were detect-
ed upon serum starvation at both type II and type III promoter
genes, consistent with enhanced MAF1 recruitment at Pol III loci
under starvation conditions (Fig. 4E, left and middle panel).
Given the preferential binding of MAF1 to Pol III loci, we
compared Pol III chromatin association profiles generated by
ChIP-seqwith those ofMAF1 obtained byDamIP-seq.We calculat-
ed MAF1 DamIP-seq scores for Pol III genes and identified 64 loci
with highly significant (P < 0.005) MAF1 enrichment and at least
one ATC within the gene body; of these loci, 52 were bound in se-
rum-starved cells (and some of them, also in serum-replete cells),
and the remaining 12 exclusively in serum-replete cells (note
that only one locus, a tRNA pseudogene, had high MAF1 score
but no ATC) (Supplemental Table S3). We then compared the 52
MAF1 targets in serum-starved cells with genes previously defined
as “unbound,” “stable,” or “unstable” based on the different Pol III
occupancy responses to serum starvation. Strikingly, MAF1 was
found to bind exclusively to Pol III–occupied loci and to preferen-
tially localize to genes with high Pol III occupancy scores (Fig. 4F)
located in a genetic environment enriched in open chromatin
marks (Supplemental Fig. S3D). MostMAF1-bound genes were un-
stable, but we also observed MAF1 binding to some stable genes,
with a similar proportion of MAF1-bound genes in both categories
(14% of unstable genes and 10% of stable genes) (Fig. 4F).
Upon close examination of the MAF1-bound genes, we no-
ticed that 91% of them contained a GATC sequence, suggesting
that DamK9A may still retain a preference for a G in the first posi-
tion upstream of the ATC motif, a possibility raised previously
(Xiao et al. 2012). Since only 32% of the remaining Pol III–occu-
pied genes (with no detectable MAF1) contain a GATC, a number
of binding events might have been lost due to the lesser availabil-
ity of potential Dam sites. This possibility, however, does not affect
the conclusions that (1) MAF1 preferentially binds to Pol III–occu-
pied genes, as we have no example of MAF1 binding to Pol III–
devoid loci, and (2) the proportions ofMAF1-bound genes are sim-
ilar in the stable and unstable categories, as they remain similar
even if we consider only GATC-containing genes (25% of unstable
and 30% of stable). Taken together, these results show enhanced
association of MAF1 to a subset of Pol III–bound genes in response
to serum starvation.
Discussion
An unexpectedly nuanced program for regulation of Pol III
recruitment in response to environmental cues
In yeast, Pol III occupancy is uniformly reduced in stationary
phase compared with exponentially growing cells (Harismendy
et al. 2003). The present work reveals that in mammalian cells, in-
dividual Pol III loci show a broad range of adaptation to growth
conditions; this is far from the uniform response onemight expect
from the action ofMAF1, a protein targeting the polymerase rather
than individual promoters. Our ChIP-seq analyses in IMR90hTert
cells reveal that about one-third of Pol III loci tend to have poor
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Figure 4. DamIP-seq showsMAF1 recruitment at Pol III–bound genes. (A) Schematic representation ofMAF1-DamK9A and EGFP-DamK9A chimeric con-
structs depicting the position of PCR primers. Two stable IMR90hTert clonal cell lines expressing each chimera (MAF1-A,MAF1-B and EGFP-A, EGFP-B) were
generated, and mRNA expression was validated via RT-PCR. The left and right blot panels show reactions containing (+RT) or not containing (−RT) reverse
transcriptase. (B) Western blotting of whole-cell extracts or α-HA immunoprecipitates from the cell lines described in A. (C) Genomic DNA from MAF1-
DamK9A–expressing and EGFP-DamK9A–expressing IMR90hTert cell lines was extracted after 8 h of serum starvation, digested with either DpnII or
Sau3A, and analyzed by qPCR with tDNA-specific primers (upper panel). The qPCR signal (lower panel) was normalized against an intergenic region on
Chr21 and is shown as DpnII versus Sau3A ratio in arbitrary units (A.U.). Data aremean ± SD (n = 3). (∗) P < 0.05; (∗∗) P < 0.01; (∗∗∗) P < 0.001 (as calculated
by Student’s t-test). PCR primers and tDNA HUGO nomenclature are indicated in Supplemental Table S4. (D) Score versus average plots showing MAF1
association within 400-bp bins across the genome. The DamIP-seq score, defined as the log2 (MAF1tag count/EGFPtag count), is plotted on the x-axis, and the
log2 of the mean MAF1 and EGFP DamIP-seq normalized tag counts is plotted on the y-axis, in each case for nonoverlapping 400-bp bins across the ge-
nome. The dotted line indicates the cutoff, set at the lowest score giving an FDR < 0.005. Pol III loci–containing bins are represented as red or blue triangles.
(E) Meta-sample profiles depicting sequence coverage in a ±2-kb window surrounding the annotated 5′-ends of isolated (i.e., separated from each other by
at least 2 kb) tRNA genes, type III promoter genes, and gene-free regions. MAF1 DamIP-seq scores per nucleotide are normalized for total tag count and
calculated as the log2 (MAF1/EGFP). Signal for the +serum and −serum experiments is indicated in orange and blue, respectively. In the left panel, the
dotted lines show Pol III–unbound tDNAs; the solid lines, Pol III–bound tDNAs. (F) Overlap between MAF1 (blue dots) and Pol III associated loci (boxes)
in serum-starved IMR90hTert cells. Genes are ranked by Pol III SS ChIP-seq scores and split into Pol III unbound, bound-stable, and bound-unstable classes
according to FBS versus SS ChIP-seq fold-change (Fig. 1C, blue). Only genes having at least one ATC within the gene body are considered.
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promoters and are generally devoid of histone marks associated
with actively transcribed chromatin. These genes do not bind
Pol III in any of the growth conditions tested, consistent with per-
sistent silencing. The remaining genes bind Pol III but can be di-
vided into two broad classes that differ greatly in their response
to environmental cues. Class I (unstable genes) is the largest and
contains genes whose Pol III occupancy varies according to cell
growth conditions, being higher in favorable conditions (FBS
and SS + I) and much lower in stress conditions (SS, SS + R + I).
Exposure of serum-starved cells to insulin causes a general increase
in Pol III occupancy on these genes, and this effect is inhibited in
the presence of rapamycin, revealing that insulin regulation of
mammalian Pol III occupancy is strictly dependent on mTORC1
activity. Class II (stable genes) includes 49 genes with generally
high Pol III occupancy scores that do not vary significantly upon
serum starvation. Despite their small number, stable genes encode
for most tRNA isotypes and some RNAs involved in diverse func-
tions, such as pre-mRNA splicing, tRNA and rRNA processing,
and the control of Pol II transcription elongation.
Pol III occupancy is a proxy of ongoing transcription
In mammalian cells, Pol II is often bound near the TSS of coding
genes (Guenther et al. 2007; Danko et al. 2013) in a poised or
paused state fromwhich it can rapidly escape into productive elon-
gation in response to environmental cues (Adelman and Lis 2012).
The identification of stable loci, showing high Pol III occupancy
even upon serum starvation, raised the possibility that Pol III is
also in an arrested, unproductive state at selected genes, perhaps
to rapidly re-enter transcription when conditions are favorable.
Although stalling of Pol III at a few loci has been suggested based
on a comparison of ChIP-seq and RNA-seq profiles (Raha et al.
2010), it has not been shown experimentally, in part because stan-
dard techniques to evaluate transcriptional activity, such as GRO-
seq (Core et al. 2008), are not customized to the short (∼70–300
bp) Pol III genes. By using neusRNA-seq to quantitatively assess
Pol III transcription during the response of human fibroblasts to
serum deprivation, we reveal a correlation between Pol III occu-
pancy and active transcription.While it remains possible that, dur-
ing its transcription cycle, Pol III is transiently poised within the
preinitiation complex or stalled in a post-recruitment step, the ab-
sence of genes with high Pol III occupancy and low RNA output in
serum-starved conditions strongly argues against the presence of
arrested, unproductive Pol III and confirms the existence of a
group of Pol III genes that remain actively transcribed under ad-
verse conditions. Adaptation and continued synthesis of certain
RNAsmayhave evolved to coordinate the Pol II and Pol IIImachin-
eries with changing conditions and ensure cell survival during pe-
riods of stress. Indeed, in higher eukaryotes the relative amount of
tRNA isoacceptors in the overall pool has been reported to coordi-
nate, through an unknown mechanism, with the translational
needs of the cell and to adapt to match the codon usage of protein
coding genes selectively expressed in a certain tissue or prolifera-
tive state (Gingold et al. 2014; Schmitt et al. 2014).
A model for MAF1 repression of transcribing Pol III
In yeast, Maf1 has been shown to be increasingly recruited to Pol
III genes after rapamycin treatment (Oficjalska-Pham et al. 2006;
Roberts et al. 2006). To assess the contribution of mammalian
MAF1 to the differential stress response of Pol III genes,wemapped
genome-wide MAF1 binding sites in normal and serum-starved
IMR90hTert cells. Despite a number of studies showingMAF1 asso-
ciation with individual Pol III genes and Pol II promoters by ChIP-
qPCR experiments (Johnson et al. 2007; Goodfellow et al. 2008;
Rohira et al. 2013), an analysis on the genomic scale has not
been reported in mammalian cells. The unavailability of MAF1
ChIP-seq binding profiles might be explained by the transient na-
ture of the interaction betweenMAF1 and Pol III transcribed genes,
which would make ChIP-seq signals difficult to detect. To identify
MAF1 genomic binding sites, we therefore turned to the DamIP-
seq method, which does not depend on the stable association of
proteins and DNA at the time of cross-linking and provides a
way to mark transient protein–DNA interaction sites in vivo.
DamIP-seq revealed a strong preference for MAF1 localization at
Pol III–bound loci, and we detected significant MAF1 enrichment
at 64 type II and type III promoter genes. This number is almost
certainly an underestimation due to the relatively low sequence
coverage of the DamIP-seq experiment and the fact that
DamK9Amethylation may depend on the availability of potential
GATC targets, which are absent in a large fraction of Pol III loci.
Besides Pol III repression, MAF1 has been reported to repress
Pol II transcription by direct binding to specific Pol II promoters,
including those of the TBP, EGR1 (Johnson et al. 2007), and
FASN (Palian et al. 2014) genes. Our results failed to identify
MAF1 interaction with these promoters, even though they all in-
clude a GATC motif in proximity of the TSS. Although we cannot
exclude that MAF1 binding goes undetected at the TBP, EGR1, and
FASN genes because of a sequence context that restricts DamK9A
targeting, the very low MAF1 scores observed at Pol II genes do
not provide evidence for MAF1 acting as a Pol II transcription
factor.
Our DamIP-seq analysis reveals that MAF1 occupancy in-
creases at Pol III loci after serum starvation, correlating with de-
creased MAF1 phosphorylation and a decreased Pol III
occupancy. Moreover, siRNA-mediated down-regulation of MAF1
results in higher Pol III occupancy in serum-starved condition.
These observations strongly suggest that MAF1 mediates, at least
in part, the down-regulation of Pol III occupancy after serum star-
vation. The finding that MAF1 is preferentially associated with Pol
III–bound genes enriched in open chromatin marks is consistent
with MAF1 targeting of actively transcribed genes and reveals
thatMAF1 acts as a repressor of ongoing Pol III transcription rather
than as a long-term silencing factor. Unexpectedly, MAF1 was also
detected on five stable genes whose Pol III occupancy score did not
change significantly after serum starvation. The negligible effect of
MAF1 on stable genes might be explained by their relatively high
Pol III content. Since protein abundance studies in human cell
lines estimate that MAF1 is four- to 10-fold less abundant than
most Pol III–specific subunits (Beck et al. 2011; Kulak et al.
2014), it is conceivable that highly occupied genes have a lesser
sensitivity to MAF1 repression than do genes displaying average
Pol III occupancy. A second possibility is that facilitated recycling
contributes to the stability of stable Pol III loci during stress condi-
tions, given that MAF1 association with the polymerase itself does
not inhibit elongation of transcriptionally engaged Pol III
(Vannini et al. 2010) or facilitated recycling (Čabart et al. 2008).
Additionally, Pol III activity may be affected by other players mod-
ulating theMAF1 effect, such as the previously proposed casein ki-
nase 2 (Boguta and Graczyk 2011), or by putative MAF1 binding
partners brought in close proximity of Pol III genes. For example,
MAF1 has recently been shown to interact with PCNA (Cooper
et al. 2015), a member of the DNA sliding clamp family with the
ability to inhibit EP300 acetyltransferase activity (Hong and
Chakravarti 2003). It is conceivable that MAF1-delivered PCNA
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could repress transcription of Pol III,
which contains a PCNA binding site in
the POLR3E (Rpc5) subunit (Gilljam
et al. 2009), by preventing histone acety-
lation in the vicinity of Pol III genes. This
mechanismmight counteract the report-
ed MYC-TRAPP–mediated acetylation
and activation of Pol III genes’ transcrip-
tion in prosurvival conditions (Kenneth
et al. 2007).
Importantly, our DamIP-seq analy-
sis revealed not only that MAF1 associa-
tion with Pol III genes increases after
serum starvation but also that MAF1 as-
sociation with Pol III genes is not limited
to stress conditions. While we observed
increased MAF1 targeting of active Pol
III genes after serum starvation, MAF1
was detected at numerous genes in nor-
mally growing cells (Fig. 4D,E). In agree-
ment with these results, MAF1 knock-
down by RNAi results in increased Pol
III transcription from a RNU6 promoter
even in the absence of stress (Reina
et al. 2006), and liver from Maf1−/−
mice fed ad libitum displays increased
Pol III occupancy compared with liver
from wild-type mice (Bonhoure et al.
2014). Our work indicates that, even un-
der favorable growth conditions, mam-
malian Pol III genes, like yeast Pol III
genes, which were found significantly
occupied byMaf1 even before rapamycin
treatment (Oficjalska-Pham et al. 2006;
Roberts et al. 2006), are targeted by
MAF1, possibly to partially repress tran-
scription and avoid overproliferation.
MAF1 is thus not only an acute but
also a chronic repressor of Pol III
transcription.
Our results lead to the model sum-
marized in Figure 5, which clarifies the
mechanisms responsible for genome-
wide modulation of Pol III transcription
in response to nutrient availability in hu-
man cells. When nutrients are available
and mTORC1 is active, a large fraction
of MAF1 is hyperphosphorylated and most Pol III is engaged in
transcription. Stress-induced MAF1 dephosphorylation results in
increased targeting of gene-bound Pol III, which would then fall
off the template and fail to reinitiate, with a consequent decrease
in the transcriptional readout. On “stable” genes, MAF1 binding
would have little or no consequence, possibly because of stoichio-
metric constraints or additional regulators.
In the absence of a mechanism blocking the polymerase on
the DNA, binding of MAF1 to Pol III genes might suffice as an
on/off switch for rapid transcriptional regulation of the majority
of loci. Since pausing of Pol II has arguably evolved as a means
to facilitate synchronous and rapid transcriptional activation by
bypassing a number of rate-limiting steps (Adelman and Lis
2012), it is reasonable to think that maintaining Pol III on the
DNA in an unproductive state in unfavorable conditions is not re-
quired, given that de novo recruitment of the enzyme is compara-
tively a much simpler process.
Methods
Cell culture and transfections
IMR90hTert (Canella et al. 2010) cells were cultured at 37°C under
5% CO2 in DMEM supplemented with 10% fetal bovine serum
(FBS), 100 U/mL penicillin, and 100 µg/mL streptomycin unless
otherwise specified. For ChIP-qPCR, ChIP-seq, and immunoblot-
ting, 70%–80% confluent IMR90hTert cells were serum-starved
for 8 h and restimulated for 90 min with 1 µM insulin (Sigma,
I9278) directly or after treatment with 2 nM rapamycin
(Calbiochem, 553211) for 45 min. For neusRNA-seq and
Figure 5. Model depicting MAF1-dependent regulation of Pol III transcription under different growth
conditions. The tRNA molecules in red and green derive from unstable and stable genes, respectively.
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Northern blotting of labeled RNAs, 70%–80% confluent
IMR90hTert cells were serum-starved for 5 h and labeled with
0.25 mM 5-EU (Life Technologies, E-10345) or DMSO for 5 h.
Where indicated, Lipofectamine RNAiMax (Life Technologies,
13778-075) was used to transfect IMR90hTert cells with silencer se-
lect MAF1-specific siRNAs (Ambion, catalog 4427037, id. s38693
#siRNA1 and s38691 #siRNA2) or a nontarget siRNA (Ambion, cat-
alog 4390843); 36 h after transfection cells were serum-starved for
8 h where indicated. To generate stable cell lines for DamIP-seq,
IMR90hTert cells were transfected with the relevant plasmids
at a 1:2.5 DNA:FugeneHD (Promega, E2312) ratio according to
the manufacturer’s instructions and selected with 1 µg/mL of
puromycin.
ChIP-seq and ChIP-qPCR
Chromatin immunoprecipitation was carried out as previously de-
scribed (Canella et al. 2010) using 8 µL per 107 IMR90hTert cells of
an anti-POLR3D antibody. The detailed protocol and modifica-
tions are described in Supplemental Methods.
neusRNA-seq
IMR90hTert cells grown in a 10-cmdish as indicatedwere collected
by centrifugation (6 min, 600g, 4°C) and washed twice with 1×
PBS. Cell pellets were resuspended in 700 µL of TRIzol (Life
Technologies, 15596026), homogenized with 140 µL of chloro-
form, and centrifuged for 15min at 12,000g and 4°C. To selectively
enrich in RNAs <400 nt, including most Pol III–transcribed RNAs,
the aqueous phase was diluted with 1 volume of 48% ethanol be-
fore proceeding to RNA extraction with the RNeasy kit (Qiagen,
74104). Two micrograms of the small RNA-enriched fraction was
used for biotinylation and bead-purified with the click-iT
Nascent RNA capture kit (Life Technologies, C10365) according
to themanufacturer’s instructions. RNA on beads was resuspended
in RNase-free water, heated 5min at 70°C, and used for first-strand
cDNA synthesis with random hexamers and SuperScript Vilo mas-
termix (Life Technologies, 11755050) as described by the supplier.
After heating the beads for 5min at 85°C, the supernatant contain-
ing single-stranded cDNA was purified with NucleoSpin columns
(Macherey-Nagel, 740609) and NTC buffer. The cDNA was used
for library generation with the TruSeq RNA sample prep v2 kit
(Illumina, RS-122-2001) according to the manufacturer’s instruc-
tions, but with NucleoSpin columns and NTC buffer when re-
quired instead of AmpureXP beads. In brief, samples were diluted
with 8 µL of FSM before second-strand synthesis, end repair, 3′-
adenylation, and adapter ligation. DNAwas PCR amplified, size se-
lected (150–500 bp) on a 4% agarose gel, and eluted in 26 µL of EB
buffer before multiplex (three indexes per lane) sequencing with
the Illumina HiSeq 2000 platform. This library preparation strat-
egy has the advantages to both prevent potential loss of Pol III
transcripts with 3′cyclic phosphates (Lund and Dahlberg 1992)
and preserve small cDNA fragments (>20 nt) that might arise
from premature RT termination at modified nucleotides (Motorin
et al. 2007). For read size distribution, see Supplemental Figure S4.
DamIP-seq and digestion assay
IMR90hTert cells expressing HA-tagged MAF1-DamK9A or EGFP-
DamK9A were serum-starved for 8 h where indicated, and gDNA
was extracted with the DNeasy kit (Qiagen, 69504) following the
supplier’s instructions (including RNase A treatment). For the
digestion assay, 200 ng of gDNA was digested with 5 U of either
DpnII (NEB, R0543S) or Sau3A (NEB, R0169L), purified on column
(MN, 740609), and analyzed by qPCR with primers listed in
Supplemental Table S4. DamIP-seq was as previously described
(Xiao et al. 2010, 2012) with modifications. In brief, 10 µg of
gDNA was sheared to 100–300 bp with a Covaris S220 focused-
ultrasonicator in 6 × 16 mm µTUBE (Covaris, catalog 520045).
The DNA was boiled for 10′ at 98°C, cooled for 10′ in ice, diluted
with 1 volume of ice-cold 2X DamIP buffer (20 mM Tris-Cl at pH
7.4, 300 mM NaCl, and 0.2% NP40), and incubated O/N at 4°C
under rotation with 4 µg of anti-N6-methyladenosine anti-
body (Millipore, 1 µg/µL, ABE572). Antibody–DNA complexes
were pulled-down with 25 µL of Dynabeads protein-A (Life
Technologies, 10002D) by 1-h incubation at room temperature.
Beads were washed four times in 1×DamIP buffer and resuspended
in 300 µL of elution buffer (50 mM Tris-Cl at pH 8, 10 mM EDTA,
and 0.5% SDS) with 40 µg of proteinase K. After 3-h incubation at
48°C, immunoprecipitated single-stranded DNA (ssDNA) was ex-
tracted with phenol chloroform, ethanol precipitated, and resus-
pended in 17 µL of EB buffer. Approximately 100 ng of ssDNA
was used for library generation with the TruSeq RNA sample
prep v2 kit (Illumina, RS-122-2001) as described for the
neusRNA-seq protocol, except that 200- to 300-bp DNA fragments
were size-selected on a 4% agarose gel before PCR amplification.
Data analysis
For ChIP-seq, we mapped the sequence tags obtained after ultra-
high-throughput sequencing onto the UCSC genome hg19 as pre-
viously described (Renaud et al. 2014), allowing up to 500multiple
matches across the genome. Data were scaled to the mean of total
tag count, and Pol III scores were calculated for bins including the
annotated gene body ±150 bp as the mean log2 (IPtag count/
INPUTtag count) of two replicates per condition. Cutoffs to define
Pol III–bound genes were calculated as previously described
(Canella et al. 2010), except that for tags sequencedmultiple times,
we included up to 100 copies instead of 50. Two-by-two compari-
sons between ChIP-seq scores from different growth conditions
were done using the Limma package (Smyth 2005). For compari-
son of Pol III ChIP-seq scores with epigenetic marks and DHS,
raw tags from publicly available data sets were downloaded from
the Sequence Read Archive (SRA) and then mapped with the pro-
cedure described above. As the input was not always available, the
gene scores were calculated using only the IP tags. The combined
A-box and B-box score was calculated as follows: By using MEME
(Bailey et al. 2009) on the 25%most highly occupied tRNA genes,
we extracted a position-specific scoringmatrix (PSSM) for both the
A-box and B-box regions. We then calculated the E-value for each
Pol III gene using MAST with the two PSSMs generated above. The
plotted scores are given as −log10 (E-value).
For neusRNA-seq, sequenced tags were first cleared of adapt-
ers with Cutadapt (Martin 2011), leaving tags with sizes ranging
between 19 and 99 nt. The tagswere thenmapped in three sequen-
tial steps and categorized as either mature or precursors as previ-
ously described (Bonhoure et al. 2015). Each tag contribution to
the gene score was weighted according to its length, its number
of matches on the transcriptome, and the number of times it
was sequenced. A cutoff for tags with multiple matches was calcu-
lated as a function of the tag length with the following approach.
By using the reference list of human loci shown in Supplemental
Table S2, we generated a list of all possible tags with a length vary-
ing between 19 and 99. For each length, we identified the tag with
the maximum number of matches in the Pol III loci reference and
applied this number as the cutoff for the neusRNA-seq sequenced
tags of this specific length; any tag of this lengthwith a larger num-
ber of possible matches in the entire genome was discarded. For
any tag with a possible number of matches in the entire genome
below or equal to the cutoff number, the tag contribution to the
gene score was calculated as the number of times it was sequenced
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divided by the number of matches in the Pol III loci reference. To
build scores, we first calculated for each gene the mean of three
negative DMSO control replicates and then subtracted this value
to the gene tag count of every EU-labeled sample. The mean score
of three EU-labeled replicates was then calculated for each condi-
tion (with or without serum) and used for the analysis described
in the text.
For DamIP-seq, the tags were trimmedwith Cutadapt (Martin
2011), and the mapping, scoring, and cutoff procedures used for
ChIP-seqwere applied. Supplemental Figure S5 shows that the cor-
relations among MAF1 DamIP-seq samples were relatively high,
whereas those among the EGFP control DamIP-seq samples were
low, as expected. Because of low sequence coverage, we generated
ameta-sample consisting of sequenced tags from four experiments
per condition (two replicates per clone, two clones per condition).
The data were scaled to the mean of total tags count before calcu-
lation of scores. Thewhole genomewas split into 400-bp bins, and
bin scores were calculated as the mean log2 (MAF1tag count/EGFPtag
count) for each condition. Bins having (1) more than eight tags in
the MAF1-expressing clones and (2) a positive score were plotted.
Bins having a score bigger than a certain cutoff, chosen as the low-
est score giving a FDR of 0.005 on the whole genome and calculat-
ed as previously described (Renaud et al. 2014), were associated to
the corresponding genomic feature (Supplemental Table S3). For
Pol III genes, scores were calculated as above, but on a region cen-
tered on the gene body ±150 bp.
Data access
The sequencing data from this study have been submitted to the
NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.
nih.gov/geo/) under accession number GSE73936.
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